Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTD) in Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-Risk Patients in Cassiopeia

Affiliation auteurs!!!! Error affiliation !!!!
TitreDaratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTD) in Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-Risk Patients in Cassiopeia
Type de publicationJournal Article
Year of Publication2020
AuteursSonneveld P, Attal M, Perrot A, Hulin C, Caillot D, Facon T, Leleu X, Belhadj K, Karlin L, Benboubker L, Levin M-D, Minnema MC, Westerman M, Delforge M, Zweegman S, Pei L, de Boer C, Vanquickelberghe V, Kampfenkel T, Moreau P
JournalBONE MARROW TRANSPLANTATION
Volume55
Pagination124-126
Date PublishedDEC
Type of ArticleMeeting Abstract
ISSN0268-3369